310 related articles for article (PubMed ID: 28418949)
1. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
Hanneman K; Kadoch M; Guo HH; Jamali M; Quon A; Iagaru A; Herfkens R
Clin Nucl Med; 2017 Jul; 42(7):e328-e334. PubMed ID: 28418949
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
4. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
5. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
6. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
8. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Aitken M; Chan MV; Urzua Fresno C; Farrell A; Islam N; McInnes MDF; Iwanochko M; Balter M; Moayedi Y; Thavendiranathan P; Metser U; Veit-Haibach P; Hanneman K
Radiology; 2022 Sep; 304(3):566-579. PubMed ID: 35579526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
11. MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.
Lu Y; Sweiss NJ
Clin Nucl Med; 2015 Dec; 40(12):973-4. PubMed ID: 26544904
[TBL] [Abstract][Full Text] [Related]
12. Combined FDG PET/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac Sarcoidosis.
Marschner CA; Aloufi F; Aitken M; Cheung E; Thavendiranathan P; Iwanochko RM; Balter M; Moayedi Y; Duero Posada J; Hanneman K
Radiol Cardiothorac Imaging; 2023 Oct; 5(5):e220292. PubMed ID: 38076597
[TBL] [Abstract][Full Text] [Related]
13. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
[TBL] [Abstract][Full Text] [Related]
16. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
[TBL] [Abstract][Full Text] [Related]
17. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
Nensa F; Tezgah E; Poeppel TD; Jensen CJ; Schelhorn J; Köhler J; Heusch P; Bruder O; Schlosser T; Nassenstein K
J Nucl Med; 2015 Feb; 56(2):255-60. PubMed ID: 25552667
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
[No Abstract] [Full Text] [Related]
19. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
20. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
